Sahar Saleem

Dr. Sahar Saleem

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2015 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
SSSahar Saleem
Sahar Saleem
Deepak AnandDeepak Anand
Deepak Anand
FKFirdous Khanday
Firdous Khanday
P66Shc, a member of the ShcA (Src homologous- collagen homologue) adaptor protein family, is one of the three isoforms of this family along with p46Shc and p52Shc. p66Shc, a 66 kDa protein is different from the other isoforms of the ShcA family. p66Shc is the longest isoform of the ShcA family. p66Shc has an additional CH domain at the N-terminal, called the CH2 domain, which is not not present in the other isoforms. This CH2 domain contains a very crucial S36 residue which is phosphorylated in response to oxidative stress and plays a role in apoptosis. Whereas p52Shc and p46Shc are ubiquitously expressed, p66Shc shows constrained expression. This adaptor protein has been shown to be involved in mediating and executing the post effects of oxidative stress and increasing body of evidence is pinpointing to its role in carcinogenesis as well. It shows proto-oncogenic as well as pro-apoptotic properties. This multitasking protein is involved in regulating different networks of cell signaling. On one hand it shows an increased expression profile in different cancers, has a positive role in cell proliferation and migration, whereas on the other hand it promotes apoptosis under oxidative stress conditions by acting as a sensor of ROS (Reactive Oxygen Species). This paradoxical role of p66Shc could be attributed to its involvement in ROS production, as ROS is known to both induce cell proliferation as well as apoptosis. p66Shc by regulating intracellular ROS levels plays a crucial role in regulating longevity and cell senescence. These multi-faceted properties of p66Shc make it a perfect candidate protein for further studies in various cancers and aging related diseases. p66Shc can be targeted in terms of it being used as a possible therapeutic target in various diseases. This review focuses on p66Shc and highlights its role in promoting apoptosis via different cell signaling networks, its role in cell proliferation, along with its presence and role in different forms of cancers.

27 March 2024 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
IMInsha Mehraj
Insha Mehraj
AHAflaq Hamid
Aflaq Hamid
UGUbaid Gani
Ubaid Gani
NINulevino Iralu
Nulevino Iralu
TMTasaduq Manzoor
Tasaduq Manzoor
SSSahar Saleem
Sahar Saleem

4 December 2018 in Cell Proliferation
Verified
Journal Article
Open access
PDF file
SSSahar Saleem
Sahar Saleem
RARoshia Ali
Roshia Ali
FKFirdous Khanday
Firdous Khanday
Syntrophins are a family of 59 kDa peripheral membrane‐associated adapter proteins, containing multiple protein‐protein and protein‐lipid interaction domains. The syntrophin family consists of five isoforms that exhibit specific tissue distribution, distinct sub‐cellular localization and unique expression patterns implying their diverse functional roles. These syntrophin isoforms form multiple functional protein complexes and ensure proper localization of signalling proteins and their binding partners to specific membrane domains and provide appropriate spatiotemporal regulation of signalling pathways. Syntrophins consist of two PH domains, a PDZ domain and a conserved SU domain. The PH1 domain is split by the PDZ domain. The PH2 and the SU domain are involved in the interaction between syntrophin and the dystrophin‐glycoprotein complex (DGC). Syntrophins recruit various signalling proteins to DGC and link extracellular matrix to internal signalling apparatus via DGC. The different domains of the syntrophin isoforms are responsible for modulation of cytoskeleton. Syntrophins associate with cytoskeletal proteins and lead to various cellular responses by modulating the cytoskeleton. Syntrophins are involved in many physiological processes which involve cytoskeletal reorganization like insulin secretion, blood pressure regulation, myogenesis, cell migration, formation and retraction of focal adhesions. Syntrophins have been implicated in various pathologies like Alzheimer’s disease, muscular dystrophy, cancer. Their role in cytoskeletal organization and modulation makes them perfect candidates for further studies in various cancers and other ailments that involve cytoskeletal modulation. The role of syntrophins in cytoskeletal organization and modulation has not yet been comprehensively reviewed till now. This review focuses on syntrophins and highlights their role in cytoskeletal organization, modulation and dynamics via its involvement in different cell signalling networks.

19 May 2022 in Plant Protection Science
Verified
Journal Article
Open access
PDF file
AHAflaq Hamid
Aflaq Hamid
SSSahar Saleem
Sahar Saleem
Role of nanoparticles in management of plant pathogens and scope in plant transgenics for imparting disease resistance | Aflaq Hamid, Sahar Saleem | Agricultural Journals

30 January 2021 in The Protein Journal
Verified
Journal Article
Closed access
PDF file
RARoshia Ali
Roshia Ali
HMHilal Ahmad Mir
Hilal Ahmad Mir
RHRabia Hamid
Rabia Hamid
RSRiaz A. Shah
Riaz A. Shah
FKFirdous Khanday
Firdous Khanday
SSSahar Saleem
Sahar Saleem

1 March 2025 in Functional & Integrative Genomics
Verified
Journal Article
Closed access
PDF file
AZAmbreen Zahoor
Ambreen Zahoor
RKRafia Khazer
Rafia Khazer
IMInsha Mehraj
Insha Mehraj
UGUbaid Gani
Ubaid Gani
FFFalah Fayaz
Falah Fayaz
SSSahar Saleem
Sahar Saleem